معرفی
Michael Jennings is a Professor in the Department of Physiology and Cell Biology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. After stepping down as Department Chair in July 2020, he continues as a part-time faculty member focusing on teaching, curriculum development, and educational administration while collaborating on research projects.
His educational background is highlighted by a Ph.D. from Harvard University.
- Ph.D., Harvard University
Dr. Jennings' research centers on membrane transport proteins, particularly anion exchangers (Band 3/AE1) and cation-chloride cotransporters, with emphasis on molecular mechanisms and human disease connections. His work spans from fundamental biophysics of transport to disease implications including diastrophic dysplasia, corneal clouding, and bone metabolism disorders. Recent investigations have expanded into iron transport pathways and their physiological consequences.
Analysis of his 2015-2025 publications reveals a dominant focus on ion transport kinetics, with increasing attention to disease pathophysiology. Key themes include molecular characterization of anion exchange mechanisms, regulatory pathways of cotransporters, and physiological impacts of transporter dysfunction in conditions like osteoporosis and corneal edema, demonstrating consistent evolution from basic science to translational applications.
His research program has been continuously supported by NIH funding, including a 30-year R01 grant (GM026861) on AE1, a 10-year R01 (HL037479) on K+/Cl- cotransport, and an R21 grant on SLC4A11.
Dr. Jennings leads the Jennings Lab, which has produced seminal contributions to membrane transport physiology through innovative experimental approaches and collaborative investigations into transporter-disease relationships.
